Harvard Institute of Health Policy Study

COMMERCIAL INTERESTS IMPEDE SHARING AMONG SCIENTISTS

Genetics researchers at some universities are letting their personal financial interests impede scientific progress. David Blumenthal and his colleagues at the Harvard Institute of Health Policy found that one of every five professors in the life sciences had delayed publication of research results for at least half a year in order to protect financial interests. Those scientists who directly engaged in the commercialization of their research were three times more likely to delay publication and twice as likely to refuse to share information than those doing basic work. Among the life scientists, geneticists were the most likely to withhold data from other researchers. [ Read More ]
David Blumenthal

Experimental Drugs

DOCTORS GET BIG BUCKS FOR PUTTING PATIENTS ON EXPERIMENTAL DRUGS

"Financial advisers who sell you insurance or mortgages are required by the rules to tell you how much commission they will earn as a result of your custom," write Jammi Rao and L.J. Sant Cassia in the British Medical Journal. "But doctors who ask patients under their care to take part in a clinical trial are under no obligation to reveal how much they might earn as a result of their patients agreeing to take part in the trial. Can this be right?" [ Read More ]


© 2007 WhoOwnsYourBody.org. All rights reserved.